News
NATICK, Mass., Dec. 28 Boston ScientificCorporation (NYSE: BSX) today announced CE Mark approval for its LIVIAN(TM)cardiac resynchronization therapy defibrillator (CRT-D), which treats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback